These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17049192

  • 1. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
    El-Ridy MS, Mostafa DM, Shehab A, Nasr EA, Abd El-Alim S.
    Int J Pharm; 2007 Feb 07; 330(1-2):82-8. PubMed ID: 17049192
    [Abstract] [Full Text] [Related]

  • 2. Niosomal encapsulation of the antitubercular drug, pyrazinamide.
    El-Ridy MS, Abdelbary A, Nasr EA, Khalil RM, Mostafa DM, El-Batal AI, Abd El-Alim SH.
    Drug Dev Ind Pharm; 2011 Sep 07; 37(9):1110-8. PubMed ID: 21417612
    [Abstract] [Full Text] [Related]

  • 3. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST, Denkin SM, Zhang Y.
    J Antimicrob Chemother; 2007 Feb 07; 59(2):313-6. PubMed ID: 17185297
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
    Gangadharam PR, Geeta N, Hsu YY, Wise DL.
    Int J Tuberc Lung Dis; 1999 Jun 07; 3(6):515-20. PubMed ID: 10383065
    [Abstract] [Full Text] [Related]

  • 5. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R, Khuller GK.
    J Antimicrob Chemother; 2004 Jul 07; 54(1):266-8. PubMed ID: 15128731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A, Sharma S, Khuller GK.
    J Antimicrob Chemother; 2004 Oct 07; 54(4):761-6. PubMed ID: 15329364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.
    Ahmad Z, Pandey R, Sharma S, Khuller GK.
    Indian J Chest Dis Allied Sci; 2006 Oct 07; 48(3):171-6. PubMed ID: 18610673
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R, Sharma S, Khuller GK.
    Tuberculosis (Edinb); 2005 Oct 07; 85(5-6):415-20. PubMed ID: 16256437
    [Abstract] [Full Text] [Related]

  • 12. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
    de Steenwinkel JE, van Vianen W, Ten Kate MT, Verbrugh HA, van Agtmael MA, Schiffelers RM, Bakker-Woudenberg IA.
    J Antimicrob Chemother; 2007 Nov 07; 60(5):1064-73. PubMed ID: 17846106
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.
    Gopal P, Grüber G, Dartois V, Dick T.
    Trends Pharmacol Sci; 2019 Dec 07; 40(12):930-940. PubMed ID: 31704175
    [Abstract] [Full Text] [Related]

  • 14. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
    Pandey R, Khuller GK.
    Tuberculosis (Edinb); 2005 Jul 07; 85(4):227-34. PubMed ID: 15922668
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics of pyrazinamide in elephants.
    Zhu M, Maslow JN, Mikota SK, Isaza R, Dunker F, Riddle H, Peloquin CA.
    J Vet Pharmacol Ther; 2005 Oct 07; 28(5):403-9. PubMed ID: 16207301
    [Abstract] [Full Text] [Related]

  • 16. The potential of azole antifungals against latent/persistent tuberculosis.
    Ahmad Z, Sharma S, Khuller GK.
    FEMS Microbiol Lett; 2006 May 07; 258(2):200-3. PubMed ID: 16640573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pyrazinamide.
    Tuberculosis (Edinb); 2008 Mar 07; 88(2):141-4. PubMed ID: 18486055
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of reticuloendothelial activity with liposomes.
    Hojo H, Hoshino Y, Kurita T, Hashimoto Y.
    Res Commun Chem Pathol Pharmacol; 1985 Mar 07; 47(3):373-85. PubMed ID: 3992015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.